The Infectious Disease Society of St. Louis (IDSTL) is pleased to welcome Robert T. Schooley, MD, Distinguished Professor Medicine at the University of California San Diego, for a compelling and clinician focused overview of the growing threat of antimicrobial resistance (AMR) and its impact on healthcare around the world. He will introduce bacteriophages (phages)—viruses that naturally target and kill bacteria—and explore their potential as a new tool for treating antibiotic-resistant infections.
Speaker

Robert T. Schooley, MD
Distinguished Professor of Medicine
University of California San Diego
Topic
Bacteriophage Therapeutics: Back to the Future? Addressing AMR bacterial infections by making good use of viruses.
About the Speaker
About the Seminar
AMR is a growing global health challenge that is making many bacterial infections increasingly difficult to treat with antibiotics. As resistance continues to rise, there is an urgent need for new approaches to fighting these infections. The session will discuss the key challenges that must be overcome before phage therapy can become a widely available treatment, including the need for more clinical research, regulatory approval, and standardized approaches to care.
This course is directed to infectious diseases physicians, pediatricians, public health specialists, infection control specialists, epidemiologists, microbiologists, and those who oversee AMR and AMS programs. Fellows are always welcome at no charge.